Patients with specialty and rare diseases face enormous challenges managing their illnesses and NAVigating healthcare dynamics. The dawn of each day brings reminders of those challenges, yet also renews hope that better treatments are on the horizon. EOS, Greek God of the Dawn that brought forth the hope of a new day, is an inspiring metaphor for the hopes of patients and the noble role that biopharma companies can play in supporting these patients. Naveos Biopharma focuses on the intersection of navigation and hope. We seek to leverage our industry expertise and partner with biopharma companies to plot a successful route through the myriad of challenging investment & development decisions needed to bring new treatments to market, all while keeping the hopes and needs of patients as a guiding light in our efforts.